Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Immunosuppressive agents for treating IgA nephropathy

Esta versión no es la más reciente

ver la versión actual 12 marzo 2020

Información

DOI:
https://doi.org/10.1002/14651858.CD003965Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 20 octubre 2003see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Riñón y trasplante

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Joshua A Samuels

    Correspondencia a: Nephrology / Pediatric Nephrology, UT‐Houston Health Science Center, Houston, USA

    [email protected]

  • Giovanni FM Strippoli

    a) Mario Negri Sud Consortium, Santa Maria Imbaro (Ch), Italy, b) Sydney School of Public Health, University of Sydney, Australia, c) Diaverum Medical‐Scientific Office, Lund, Sweden

  • Jonathan C Craig

    a) Cochrane Renal Group, Centre for Kidney Research, The Children's Hospital at Westmead, b) Sydney School of Public Health, The University of Sydney, Sydney, Australia

  • Francesco Paolo Schena

    Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy

  • Donald A Molony

    Internal Medicine, UT‐Houston Health Science Center, Houston, USA

Contributions of authors

This review is the product of an equal contribution from Joshua Samuels and Giovanni FM Strippoli, who conceived it, developed the protocol, designed and conducted the review, performed the data extraction, data analysis and wrote the final review.
Jonathan C Craig was involved in the conduct, data‐analysis and writing of the review.
Donald Molony reviewed the final draft.
Francesco P Schena reviewed the final draft

Declarations of interest

None. No reviewer has a vested interest in any of the products or procedures included in the analysis.

Acknowledgements

The authors wish to acknowledge Narelle Willis, Coordinator of the Cochrane Renal Group, for editing the original protocol and the final review. They also thank Linda Heslop, Ruth Mitchell and Gail Higgins for trial search strategies development and Sandra Puckeridge for excellent administrative assistance.
The authors are particularly indebted to Drs C. Pozzi, R.G. Walker, R. Katafuchi, O. Harmankaya for providing additional data relating to their trials upon request.

Version history

Published

Title

Stage

Authors

Version

2020 Mar 12

Immunosuppressive agents for treating IgA nephropathy

Review

Patrizia Natale, Suetonia C Palmer, Marinella Ruospo, Valeria M Saglimbene, Jonathan C Craig, Mariacristina Vecchio, Joshua A Samuels, Donald A Molony, Francesco Paolo Schena, Giovanni FM Strippoli

https://doi.org/10.1002/14651858.CD003965.pub3

2015 Aug 03

Immunosuppressive agents for treating IgA nephropathy

Review

Mariacristina Vecchio, Bibiana Bonerba, Suetonia C Palmer, Jonathan C Craig, Marinella Ruospo, Joshua A Samuels, Donald A Molony, Francesco Paolo Schena, Giovanni FM Strippoli

https://doi.org/10.1002/14651858.CD003965.pub2

2003 Oct 20

Immunosuppressive agents for treating IgA nephropathy

Review

Joshua A Samuels, Giovanni FM Strippoli, Jonathan C Craig, Francesco Paolo Schena, Donald A Molony

https://doi.org/10.1002/14651858.CD003965

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.